Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials

BACKGROUND: Alzheimer’s disease (AD) is associated with considerable costs and has a significant impact on health and social care systems. OBJECTIVE: This study assessed whether baseline comorbidities present in 2,594 patients with AD participating in two semagacestat randomized placebo-controlled t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahle-Wrobleski, Kristin, Fillit, Howard, Kurlander, Jonathan, Reed, Catherine, Belger, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646926/
https://www.ncbi.nlm.nih.gov/pubmed/25410743
http://dx.doi.org/10.1007/s10198-014-0648-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646926/
https://www.ncbi.nlm.nih.gov/pubmed/25410743
http://dx.doi.org/10.1007/s10198-014-0648-7

Ejemplares similares